R 187.63 ▲ 0.85% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ryder System Inc.

    NYSE: R · Real-Time Price · USD
    187.63
    1.58 (0.85%)
    At close: Sep 04, 2025, 11:15 AM
    0.85%
    Bid 187.39
    Market Cap 7.65B
    Revenue (ttm) 12.71B
    Net Income (ttm) 506M
    EPS (ttm) 11.75
    PE Ratio (ttm) 15.97
    Forward PE 12.4
    Analyst Buy
    Ask 187.94
    Volume 38,737
    Avg. Volume (20D) 331,304
    Open 186.15
    Previous Close 186.05
    Day's Range 185.27 - 187.98
    52-Week Range 125.54 - 189.35
    Beta 0.98

    About R

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol R
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for R stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Ryder System Inc. is scheduled to release its earnings on Oct 23, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +6.08%
    Ryder System shares are trading higher after Wolfe... Unlock content with Pro Subscription
    10 months ago
    -4.25%
    Ryder System shares are trading lower after the company reported worse-than-expected Q3 revenue results and cut its FY24 adjusted EPS guidance below estimates.
    news image

    Just now · accessnewswire.com

    Tenon(R) Medical Announces Second Peer-Reviewed Catamaran Mainsail(TM) Study Publication, Underscores Robust and Sustainable Clinical Outcomes Out to 12 Months

    ~ Clinically Significant Patient Outcomes Demonstrate Improvements in Pain (VAS) and Disability (ODI), Along with High Patient Satisfaction and Safety Profile at 12-Month Analysis ~ ~ 83% of Patients ...

    news image

    Just now · newsfilecorp.com

    Burcon Achieves First Commercial Production of Puratein(R)C Canola Protein

    Vancouver, British Columbia--(Newsfile Corp. - September 4, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based prot...

    news image

    23 hours ago · accessnewswire.com

    MainStreetChamber Holdings, Inc. Celebrates Expansion of kathy ireland(R) Laundry in Over 100 Markets Nationwide

    On-demand laundry program surges in adoption with live app, technology-driven laundromat support, and dedicated marketing expansion LAS VEGAS, NV / ACCESS Newswire / September 3, 2025 / MainStreetCham...

    news image

    6 days ago · newsfilecorp.com

    Theralase(R) Extends Warrants

    Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase ®" or the "Company"), a clinical stage pharmaceutical company pioneering ligh...

    news image

    6 days ago · zacks.com

    3 Dividend-Paying Transport Equipment & Leasing Stocks to Watch

    Here we pick three stocks, GBX, R and AL, from the Transportation - Equipment and Leasing industry, with a solid five-year dividend growth history.

    news image

    1 week ago · accessnewswire.com

    Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis

    HALIFAX, NOVA SCOTIA / ACCESS Newswire / August 26, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Tes...

    news image

    1 week ago · newsfilecorp.com

    Theralase(R) Releases 2Q2025 Financial Statements

    Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiat...

    news image

    2 weeks ago · accessnewswire.com

    enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R)

    IRVINE, CA / ACCESS Newswire / August 20, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous diseas...

    news image

    2 weeks ago · accessnewswire.com

    iFabric Announces Publication of Groundbreaking Clinical Trial Proving the Infection Control Ability of Protx2(R) And Ecopel(TM) Treated Scrubs

    MARKHAM, ON / ACCESS Newswire / August 19, 2025 / iFabric Corp. (TSX:IFA)(OTCQX:IFABF), is pleased to announce that the results of its clinical trial, "Antimicrobial-treated fabric scrubs can prevent ...

    news image

    2 weeks ago · accessnewswire.com

    Tenon(R) Medical Announces the Full Market Launch of the Catamaran(R) SE SI Joint Fusion System

    ~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~ ~ New SI Joint Fixation Device Offers a Reduced Profile in Implant Size Providing Phys...

    Add to Watchlist